Quick answers
- What is Zemplar?
- Zemplar is a brand name of Paricalcitol, a prescription medicine. The FDA NDC Directory lists 4 Zemplar products in 4 strengths and forms.
- Who makes Zemplar?
- Abbvie holds the FDA application for Zemplar (NDA020819, approved April 17, 1998).
- Is there a generic or store brand of Zemplar?
- Yes. The FDA NDC Directory lists 10 other products with the same active ingredients, strength and form as a Zemplar product, 8 of them generic. Ask your pharmacist whether one is right for you.
- Has Zemplar been recalled?
- FDA enforcement reports list 2 recalls of Zemplar products; the newest started March 24, 2016. A recall usually concerns specific lots, not every product.
What Zemplar is
Each Zemplar product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Paricalcitol · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| paricalcitol 1 ug capsule, liquid filled (oral) | Zemplar | 4 products, 4 companies | DailyMed |
| paricalcitol 2 ug capsule, liquid filled (oral) | Zemplar | 4 products, 4 companies | DailyMed |
| paricalcitol 2 ug/mL injection, solution (intravenous) | Zemplar | 1 product, 1 company | DailyMed |
| paricalcitol 5 ug/mL injection, solution (intravenous) | Zemplar | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Paricalcitol →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Companies that list Zemplar
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Zemplar products.
- AbbVie Inc.4 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 24, 2016 · Class III · Terminated · D-0833-2016
Failed Content Uniformity Specifications
Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30. — AbbVie Inc.
-
May 14, 2012 · Class II · Terminated · D-1388-2012
CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.
Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05 — Abbott Laboratories
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.